Introductory Session

10:00 a.m.

Welcome

David M. Murray, Ph.D. 
Associate Director for Prevention
Director, Office of Disease Prevention
Division of Program Coordination, Planning, and Strategic Initiatives
Office of the Director
National Institutes of Health

NIH Leadership Remarks

10:05 a.m.

Office of Research on Women’s Health 

Janine Austin Clayton, M.D., FARVO
Associate Director for Research on Women’s Health
Director, Office of Research on Women’s Health
Division of Program Coordination, Planning, and Strategic Initiatives
Office of the Director
National Institutes of Health

10:10 a.m.

National Institute on Aging

Richard J. Hodes, M.D.
Director, National Institute on Aging
National Institutes of Health

10:15 a.m.

Charge to the Panel

David M. Murray, Ph.D.
Office of Disease Prevention
National Institutes of Health

10:25 a.m.

Overview of Independent Panel Activities

Cheryl Anderson, Ph.D., M.P.H., M.S. 
Workshop & Panel Chair

10:30 a.m.

P2P Workshop Overview: Topic, Key Questions, Current National Institutes of Health Research, and Agency Perspectives

Chhanda Dutta, Ph.D.
Chief, Clinical Gerontology Branch
Acting Deputy Director, Division of Geriatrics and Clinical Gerontology
National Institutes on Aging
National Institutes of Health

10:50 a.m.

Keynote Address: Understanding the Public Health Significance of the Menopausal Transition

• Basic Biology and Symptoms of Perimenopause—Nanette Santoro, M.D.
• Rationale and Lessons from the Women’s Health Initiative—JoAnn Manson, M.D., Dr.P.H., M.P.H.

11:40 a.m.

Discussion 

Moderated by 
Cheryl Anderson, Ph.D., M.P.H., M.S.
Workshop & Panel Chair

What are the effectiveness, comparative effectiveness, and harms of treatments for menopausal symptoms in perimenopausal and early postmenopausal women?

12:00 p.m.

Meera Viswanathan, Ph.D., M.A., B.A.
RTI International–University of North Carolina Evidence-based Practice Center (RTI-UNC EPC) Presentation I

12:50 p.m.

Discussion 

Moderated by 
Cheryl Anderson, Ph.D., M.P.H., M.S.
Workshop & Panel Chair

1:00 p.m.

Lunch Break

Key Question 1a:

Do the effectiveness, comparative effectiveness, and harms of treatment vary by dose, delivery mode, formulation, or duration of treatment?

1:30 p.m.

Hormonal Therapies for Symptom Management in Perimenopause—Susan Reed, M.D., M.P.H., M.S.

1:50 p.m.

Non-Hormonal Therapies for Symptom Management: Evidence Base—JoAnn Pinkerton, M.D.

2:10 p.m.

An Individualized Approach to Treating Symptoms During the Menopause Transition—Cynthia Stuenkel, M.D.

2:30 p.m.

Discussion

Moderated by 
Cheryl Anderson, Ph.D., M.P.H., M.S.
Workshop & Panel Chair

2:50 p.m.

Break

General Session 1

Healthy Aging in Women: Supporting Overall Well-Being During the Menopause Transition—Part 1

3:00 p.m.

Moderator Perspectives—Karen Giblin

3:10 p.m.

Physical Activity and the Management of Menopausal Symptoms—Sarah Witkowski, Ph.D.

3:25 p.m.

3:40 p.m.

Hormonal Regulation of Cardiometabolic Changes—Kerrie Moreau, Ph.D.

3:55 p.m.

Heavy Bleeding During the Menopausal Transition: Pathways to Fatigue—Sioban Harlow, Ph.D.

4:10 p.m.

Discussion 

Moderated by 
Karen Giblin

4:30 p.m.

Adjourn